✦ LIBER ✦

Ovarian cancer in the elderly: Outcomes with neoadjuvant chemotherapy or primary cytoreduction

✍ Scribed by K.A. McLean; C.A. Shah; S.A. Thompson; H.J. Gray; B.E. Greer; R.E. Swensen; E.M. Swisher; H.K. Tamimi; B.A. Goff

Book ID: 113961744
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 86 KB
Volume: 111
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2008.07.065

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ovarian cancer in the elderly: Outcomes

Ovarian cancer in the elderly: Outcomes with neoadjuvant chemotherapy or primary cytoreduction

✍ Kate A. McLean; Chirag A. Shah; Sara A. Thompson; Heidi J. Gray; Ron E. Swensen; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 254 KB

Neoadjuvant Chemotherapy or Primary Surg

Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer

✍ Vergote, Ignace; Tropé, Claes G.; Amant, Frédéric; Kristensen, Gunnar B.; Ehlen, 📂 Article 📅 2010 🏛 Massachusetts Medical Society 🌐 English ⚖ 341 KB

Neoadjuvant Chemotherapy or Primary Surg

Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer

✍ Vergote, Ignace; Tropé, Claes G.; Amant, Frédéric; Kristensen, Gunnar B.; Ehlen, 📂 Article 📅 2010 🏛 Massachusetts Medical Society 🌐 English ⚖ 341 KB

collections of articles on the journal's web site The Journal's Web site (NEJM.org) sorts published articles into more than 50 distinct clinical collections, which can be used as convenient entry points to clinical content. In each collection, articles are cited in reverse chronologic order, with th

Cytoreduction and HIPEC after neoadjuvan

Cytoreduction and HIPEC after neoadjuvant chemotherapy in stage IIIC–IV ovarian cancer. Critical analysis in elderly patients

✍ Cascales-Campos, P.; Gil, J.; Gil, E.; Feliciangeli, E.; López, V.; Gonzalez, A. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 468 KB

Neoadjuvant chemotherapy equalizes the o

Neoadjuvant chemotherapy equalizes the optimal cytoreduction rate to primary surgery without improving survival in advanced ovarian cancer

✍ Salih Taşkın, Mete Güngör, Fırat Ortaç… 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 235 KB

Association between neoadjuvant chemothe

Association between neoadjuvant chemotherapy response and survival outcomes in patients undergoing interval cytoreduction for advanced ovarian cancer

✍ E. Tanner; K. Long; N. Lakhi; G. Gardner; M. Leitao; Y. Sonoda; N. Abu-Rustum; D 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 59 KB